CRO-Trusted Partner in Research

Facilities for Research & Development

Pipeline Products

Portfolio of Three Product Candidates

About us

Rasayani Biologics a Research & Development Company

25 +

Years of Experience

6

Innovative Products

34

Research Publications

RBPL is a clinical stage research and development company working on indigenously developed novel therapeutics for global markets. Company focuses on developing efficacious and safe therapies for cancer and chronic diseases such as diabetic retinopathy, renal failure, liver cirrhosis, etc.

R&D of Biotech & Nanotech Products

R&D of Biotech & Nanotech Products

Dr. Yogesh Bendale

Chairman & Managing Director

Services

Give shape to your best experiments

Pipeline Products

Meeting Unmet Patient Needs

Our portfolio consists of Three Product candidates which are based on strong clinical evidence with potential to address global needs. Some of these compounds have been in clinical use as a personalized medicine for a long time with tremendous success in India and abroad. 

NTPX-07

An Oral Platinum

First, orally administered, indigenously developed platinum-based oncology compound for prevention of Head and Neck Cancers and other solid tumors.
NTAX-44

An Oral Arsenic

First, orally administered, indigenously developed Arsenic compound for Glioblastoma (GBM), Acute Promyelocytic Leukemia (APML) and potential for other hematological malignancies and solid tumors.

NTGX - 10

An Oral Gold

Therapeutically renowned and traditionally trusted compound, optimized and enhanced for multiple applications by patented process.

Call us:

+91-020-2453 7149

OR

Email us:

info@rasayanibiologics.com

facilities

Having the best lab
facilities for you

Our Clinical Research Department comprises a team of Physicians and Clinical Research professionals who work in collaboration with the Scientists to confirm the leads.

what we do

Bedside-To-Bench Approach

Our organization strives to carry out intensive scientific studies on time tested and highly efficacious clinical remedies to translate them into leads that can be further developed into potential drug candidates that are effective and safe.

Client saying

Request a call back

We are open to collaborate on the pipeline drugs which are in the different phases of developmental pathways.

    Home